And when chatbots get stressed out, they are less likely to be useful in therapeutic settings with people. The bot’s anxiety ...

Citi reiterated a Buy rating and $1,190 price target on Eli Lilly (LLY), saying the firm expects a positive read-through to the shares on FDA’s ...

FDA is aware that some patients and health care professionals may look to unapproved versions of GLP-1 – glucagon-like peptide-1 receptor agonists – drugs, including semaglutide and tirzepatide, as an ...

Proficio Capital Partners LLC increased its holdings in Eli Lilly by 30.2% during Q4, acquiring an additional 1,562 shares. Proficio now owns 6,739 shares of Eli Lilly, valued at $5.2 million. Several ...

Eli Lilly (LLY) believes its experimental weight-loss pill could make GLP-1 treatments more accessible worldwide.

We recently published a list of 12 Best Quality Stocks to Invest in Now. In this article, we are going to take a look at ...

K reports of America’s largest pharmaceutical companies show that they continue to avoid paying much, if any, U.S. corporate income tax.

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

AbbVie Inc. enters the obesity market with GUBamy, a promising amylin analog. Click here to find out why ABBV stock is a Buy.

The Italian Global Series Festival has launched with Evangeline Lilly and Adjoa Andoh winning awards and Bille August on the ...

Amy Webb, CEO of the Future Today Strategy Group, reflects on the death of privacy and the lack of preparation for the next ...

President Donald Trump claimed that the European Union was 'set up in order to take advantage of the United States'.